Healthcare Providers and Services
Company Overview of Eddingpharm (Cayman) Inc.
Eddingpharm (Cayman) Inc. operates as a pharmaceuticals marketing company. The company engages in in-licensing, marketing, and distributing hospital pharmaceutical products in Hong Kong and China. It offers nutritional supplements, oncology drugs, and other pharmaceuticals. The company also offers products including Telatinib, an anti-angiogenic for gastric and solid tumors, ACTB1003, a multi-mode oral kinase inhibitor, and ACTB1010, a mitotic Aurora kinase oral inhibitor. The company has a joint venture with Chiesi Farmaceutici S.p. A to establish Chiesi Edding Hong Kong Limited. Eddingpharm (Cayman) Inc. is based in Wanchai, Hong Kong.
48/F Central Plaza
18 Harbour Road
852 2877 4866
852 2877 4966
Key Executives for Eddingpharm (Cayman) Inc.
Eddingpharm (Cayman) Inc. Key Developments
Similar Private Companies By Industry
|024 Pharma Inc.||Asia|
|Asia Pacific Medical Group Limited||Asia|
|Cell Therapy Technologies Centre Ltd.||Asia|
|Cheer Fine Enterprises Co., Ltd.||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Eddingpharm (Cayman) Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.